Semaglutide is FDA-approved as a long-term, chronic weight management medication with no built-in stopping point. The label specifically states it is indicated to “reduce excess body weight and maintain weight reduction long term,” meaning it’s designed to be taken indefinitely as long as it’s working and you’re tolerating it well. That said, what “long-term” looks like in practice depends on your body’s response, side effects, insurance coverage, and what happens if you stop.
The Dose Escalation Timeline
You won’t start on the full dose. Semaglutide follows a 16-week ramp-up schedule designed to let your body adjust and reduce nausea and other gut-related side effects. You begin at 0.25 mg once weekly for the first four weeks, then increase to 0.5 mg for weeks five through eight, 1 mg for weeks nine through twelve, and 1.7 mg for weeks thirteen through sixteen. Starting at week seventeen, you move to the maintenance dose, which is either 1.7 mg or the recommended 2.4 mg weekly.
Most people reach peak weight loss somewhere between 12 and 18 months on the maintenance dose. The medication continues working after that point to help maintain the loss, which is a key reason it’s prescribed without a fixed end date.
What Happens When You Stop
This is the part most people searching this question really want to know. The evidence is clear and worth taking seriously: most of the weight comes back. In the STEP 1 extension trial, participants who stopped semaglutide after 68 weeks regained an average of 11.6 percentage points of their lost weight over the following year. That left them with a net loss of about 5.6% from their starting weight, compared to the roughly 17% they had lost while on the drug.
This rebound happens because semaglutide works by suppressing appetite signals and slowing digestion. When the medication leaves your system, those signals return. Hunger increases, and the metabolic adaptations your body made during weight loss (burning fewer calories at rest) are still in effect. This is why the FDA treats obesity as a chronic condition requiring ongoing treatment rather than a short course of medication.
Muscle Loss Over Time
One concern that grows more relevant the longer you take semaglutide is how much muscle you lose alongside fat. In the STEP 1 trial, participants lost an average of 15.3 kg total, but about 6.9 kg of that, roughly 45%, came from lean mass rather than fat. That’s significantly higher than the general rule of thumb in weight loss research, which predicts about 25% of lost weight comes from lean tissue.
Losing muscle matters because it affects your metabolism, bone health, strength, and ability to stay active as you age. If you’re on semaglutide for years, resistance training and adequate protein intake become especially important to offset this effect. Not all studies show losses this dramatic, but the trend is consistent enough to plan around.
Rare but Serious Long-Term Risks
The longer you take semaglutide, the more relevant rare side effects become. Pancreatitis is the most discussed. In one weight loss trial, 3 out of 1,306 participants on semaglutide developed acute pancreatitis compared to zero in the placebo group. A larger study of over 2,200 patients on GLP-1 medications found a 2.2% rate of acute pancreatitis, though this population had an average BMI near 40, which itself raises pancreatitis risk.
If you have a history of pancreatitis, the risk is more concrete. A Cleveland Clinic review found that 10% of patients with prior pancreatitis experienced a recurrence after starting a GLP-1 medication.
Gallbladder disease is the other concern worth knowing about. Rapid weight loss (more than about 3.3 pounds per week) or losing more than 25% of your body weight increases the risk of gallstones. Semaglutide also slows the movement of bile through the gallbladder, which can contribute to sludge and stone formation. Warning signs include discomfort or fullness in the upper right abdomen, persistent nausea that doesn’t improve, consistently pale stools, or unexpectedly rapid weight loss.
Insurance May Impose Its Own Timeline
Even though semaglutide is approved for indefinite use, your insurance plan may not cover it that way. Prior authorization requirements vary widely, but a common structure involves an initial approval of six months with renewal periods of up to twelve months. Renewals typically require proof that the medication is working. Some plans require adults to show at least a 5% reduction in BMI from baseline to continue coverage.
If you don’t meet the renewal threshold, or if your plan changes its formulary, you could face a gap in treatment. Given what the data shows about weight regain after stopping, this is worth discussing with your prescriber early so you have a plan. Some patients work with specialty pharmacies or manufacturer savings programs to bridge coverage gaps, though availability and eligibility shift frequently.
The Practical Answer
There is no medical time limit on semaglutide for weight loss. You can take it for years, and the drug was approved with the expectation that many people would need to. The real constraints are practical: whether side effects remain manageable, whether your insurance keeps covering it, and whether you’re taking steps to preserve muscle mass along the way. If you do stop, expect to regain a significant portion of the weight, which is not a personal failure but a predictable biological response. Treating obesity as a condition that needs ongoing management, much like high blood pressure or high cholesterol, aligns with how the medication was designed to be used.